- Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugThe agency has once again shuffled the leadership for two top drug review offices. Elsewhere, Parabilis partnered with Regeneron and an obesity pill is headed toward an approval in China.BioPharma Dive · 2mo ago↗ source
- Merck's ADC sac-TMT gets its first global Phase 3 win ahead of scheduleAn experimental antibody-drug conjugate from Merck and China-based Kelun-Biotech succeeded in a global Phase 3 study for the first time, giving Merck a key pipeline victory as it approaches the pat…Endpoints · 2mo ago↗ source
- The Supreme Court won't take up drugmakers' IRA casesThe Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca,…